Unexpected Complication of Hydroxocobalamin Administration for Refractory Vasoplegia in Orthotopic Liver Transplant: A Case Report

A 40-year-old male with alcoholic cirrhosis and end-stage renal disease presented for simultaneous liver and kidney transplantation. Hemodialysis was utilized intraoperatively during liver transplantation. During the procedure, the patient developed refractory hypotension and ultimately received hydroxocobalamin for vasoplegia. Shortly after administration, the hemodialysis machine ceased working after a “blood leak” alarm developed. Without the ability to continue intraoperative dialysis, the kidney transplantation portion of his surgery was postponed. The patient was transferred to the intensive care unit, where he underwent continuous renal replacement therapy overnight, and his kidney transplant proceeded the following morning.

[1]  R. Thadhani,et al.  Hemodialysis Failure Secondary to Hydroxocobalamin Exposure , 2017, Proceedings.

[2]  K. Kashani,et al.  High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm , 2017, Clinical kidney journal.

[3]  M. Warner,et al.  Red urinary discolouration following hydroxocobalamin treatment for vasoplegic syndrome , 2017, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[4]  J. Hiatt,et al.  Liver Transplantation in Recipients Receiving Renal Replacement Therapy: Outcomes Analysis and the Role of Intraoperative Hemodialysis , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  B. Chui,et al.  The use of high-dose hydroxocobalamin for vasoplegic syndrome. , 2014, The Annals of thoracic surgery.

[6]  Johnny C. Hong,et al.  The Evolution of Liver Transplantation During 3 Decades: Analysis of 5347 Consecutive Liver Transplants at a Single Center , 2013, Annals of surgery.

[7]  S. Stellpflug,et al.  Hydroxocobalamin hinders hemodialysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  L. Campos,et al.  Do intraoperative hemodynamic factors of the recipient influence renal graft function? , 2012, Transplantation proceedings.

[9]  S. Thornton,et al.  Successful use of continuous renal replacement therapy after hydroxocobalamin administration , 2011 .

[10]  M. Krawczyk,et al.  The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. , 2011, Annals of transplantation.

[11]  E. Strum,et al.  The role of intraoperative hemodialysis in liver transplant patients , 2011, Current opinion in organ transplantation.

[12]  Gioia Turitto,et al.  Electrolyte disorders and arrhythmogenesis. , 2011, Cardiology journal.

[13]  A. Vitin,et al.  Treatment of severe lactic acidosis during the pre-anhepatic stage of liver transplant surgery with intraoperative hemodialysis. , 2010, Journal of clinical anesthesia.

[14]  C. Appleton,et al.  Short-Term Cardiac and Noncardiac Mortality Following Liver Transplantation , 2010, Journal of transplantation.

[15]  R. Rafii,et al.  Hemodialysis Complications of Hydroxocobalamin: A Case Report , 2010, Journal of Medical Toxicology.

[16]  Guocai Tao,et al.  Vasoplegic Syndrome During Liver Transplantation , 2009, Anesthesia and analgesia.

[17]  A. Marcos,et al.  The impact of postreperfusion syndrome on short‐term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  R. Steadman,et al.  Predictors of Hyperkalemia in the Prereperfusion, Early Postreperfusion, and Late Postreperfusion Periods During Adult Liver Transplantation , 2007, Anesthesia and analgesia.

[19]  C. Deslauriers,et al.  Hydroxocobalamin as a Cyanide Antidote , 2006, American journal of therapeutics.

[20]  G. Golor,et al.  Safety of Hydroxocobalamin in Healthy Volunteers in a Randomized, Placebo-Controlled Study , 2006, Clinical toxicology.

[21]  P. Kuo,et al.  Intraoperative fluid management during orthotopic liver transplantation. , 2004, Journal of cardiothoracic and vascular anesthesia.